Biblio

Export 144 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is N  [Clear All Filters]
2023
R. Zhang, Song, Y., and Su, X., Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities., J Alzheimers Dis, vol. 94, no. s1, pp. S367-S386, 2023.
X. Chen, Jiang, S., Wang, R., Bao, X., and Li, Y., Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects., J Alzheimers Dis, vol. 94, no. s1, pp. S173-S186, 2023.
Y. Liew, Retinasamy, T., Arulsamy, A., Ali, I., Jones, N. C., O'Brien, T. J., and Shaikh, M. Farooq, Neuroinflammation: A Common Pathway in Alzheimer's Disease and Epilepsy., J Alzheimers Dis, vol. 94, no. s1, pp. S253-S265, 2023.
L. R. White, Corrada, M. M., Kawas, C. H., Cholerton, B. A., Edland, S. E., Flanagan, M. E., and Montine, T. J., Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention., J Alzheimers Dis, vol. 95, no. 1, pp. 307-316, 2023.
R. J. Castellani, Shanes, E., McCord, M., Reish, N. J., Flanagan, M. E., Mesulam, M. - M., and Jamshidi, P., Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report., J Alzheimers Dis, vol. 93, no. 2, pp. 803-813, 2023.
S. M. Shirgadwar, Kumar, R., Preeti, K., Khatri, D. Kumar, and Singh, S. Bala, Neuroprotective Effect of Phloretin in Rotenone-Induced Mice Model of Parkinson's Disease: Modulating mTOR-NRF2-p62 Mediated Autophagy-Oxidative Stress Crosstalk., J Alzheimers Dis, vol. 94, no. s1, pp. S109-S124, 2023.
R. R. Corrigan, Labrador, L., Grizzanti, J., Mey, M., Piontkivska, H., and Casadesus-Smith, G., Neuroprotective Mechanisms of Amylin Receptor Activation, Not Antagonism, in the APP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 91, no. 4, pp. 1495-1514, 2023.
C. Castillo, Bravo-Arrepol, G., Wendt, A., Saez-Orellana, F., Millar, C., Burgos, C. F., Gavilán, J., Pacheco, C., Ahumada-Rudolph, R., Napiórkowska, M., Pérez, C., Becerra, J., Fuentealba, J., and Cabrera-Pardo, J. R., Neuroprotective Properties of Eudesmin on a Cellular Model of Amyloid-β Peptide Toxicity., J Alzheimers Dis, vol. 94, no. s1, pp. S97-S108, 2023.
X. Da, Hempel, E., Ou, Y., Rowe, O. Elizabeth, Malchano, Z., Hajós, M., Kern, R., Megerian, J. Thomas, and Cimenser, A., Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 1, pp. 359-372, 2023.
H. - L. Chen, Li, C., Wang, J., Fei, Y., Min, M., Zhao, Y., Shan, E. - F., Yin, Y. - H., Liu, C. - Y., and Li, X. - W., Non-Pharmacological Interventions for Feeding and Eating Disorders in Persons with Dementia: Systematic Review and Evidence Summary., J Alzheimers Dis, vol. 94, no. 1, pp. 67-88, 2023.
L. Huang, Lu, Z., Zhang, H., Wen, H., Li, Z., Liu, Q., and Wang, R., A Novel Strategy for Alzheimer's Disease Based on the Regulatory Effect of Amyloid-β on Gut Flora., J Alzheimers Dis, vol. 94, no. s1, pp. S227-S239, 2023.
2021
F. A. Greco, McKee, A. C., Kowall, N. W., and Hanlon, E. B., Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls., J Alzheimers Dis, vol. 82, no. 2, pp. 791-802, 2021.
N. Carcavilla, Pozo, A. Sofía, González, B., Moral-Cuesta, D., Roldán, J. Joaquín, Erice, V., and Remírez, Ade Ganuza, Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic., J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
W. Vendramini Borelli, Augustin, M. Coutinho, de Oliveira, P. Bell Felix, Reggiani, L. Casagrande, Bandeira-de-Mello, R. Gorga, Schumacher-Schuh, A. Francisco, Chaves, M. Lorena Fag, and Castilhos, R. Machado, Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic., J Alzheimers Dis, vol. 80, no. 4, pp. 1705-1712, 2021.
F. Botero-Rodríguez, Sastoque, A. Melisa Có, Escudero, J. Manuel San, and Santamaría-García, H., Neuropsychiatric Symptoms in Patients with Neurocognitive Disorder and Their Performance Between Mild and Major Stages., J Alzheimers Dis, vol. 85, no. 4, pp. 1735-1744, 2021.
W. Wei, Liu, Y., Dai, C., Baazaoui, N., Tung, Y. - C., Liu, F., and Iqbal, K., Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction., J Alzheimers Dis, vol. 82, no. 2, pp. 631-646, 2021.
L. Guzmán-Martínez, Calfío, C., Farías, G. A., Vilches, C., Prieto, R., and Maccioni, R. B., New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
F. Sorrentino, Arighi, A., Serpente, M., Arosio, B., Arcaro, M., Visconte, C., Rotondo, E., Vimercati, R., Ferri, E., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Scarpini, E., Fenoglio, C., and Galimberti, D., Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition., J Alzheimers Dis, vol. 83, no. 3, pp. 1313-1323, 2021.
M. Van Zeller, Dias, D., Sebastião, A. M., and Valente, C. A., NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease., J Alzheimers Dis, vol. 83, no. 3, pp. 939-961, 2021.
H. B. Allen, A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology., J Alzheimers Dis, vol. 84, no. 1, pp. 61-67, 2021.
S. Nakamura, Yomota, S., Ito, H., Akinaga, N., Hori, A., Chinomi, K., Suzuki, H., Uchida, K., and Asada, T., A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction., J Alzheimers Dis, vol. 81, no. 4, pp. 1579-1588, 2021.

Pages